NEOE:VRNOPharmaceuticals
Verano Holdings (NEOE:VRNO) Losses Worsen, Challenging Hopes for Margin Turnaround
Verano Holdings (NEOE:VRNO) continues to face rising losses, widening at an annual rate of 45.1% over the past five years. With revenue projected to grow just 2.4% per year, which is well behind the Canadian market’s 5% pace, the company’s negative profit margins and lack of improvement in earnings keep the focus on its unprofitable core business. Still, its discounted valuation compared to pharmaceutical peers offers a glimmer of reward for investors seeking value in an otherwise challenging...